These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26885437)

  • 21. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulins in dermatology. Part 1: biological mechanisms and methods of administration.
    Forbat E; Ali FR; Al-Niaimi F
    Clin Exp Dermatol; 2018 Jul; 43(5):513-517. PubMed ID: 29774583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous immunoglobulins treatment of patients with Graves' ophthalmopathy].
    Leibe A; Levy Y; Shoenfeld Y
    Harefuah; 2001 May; 140(5):392-4, 455, 454. PubMed ID: 11419058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous immunoglobins (IVIGs) to prevent and treat infectious diseases.
    Cross AS
    Adv Exp Med Biol; 1995; 383():123-30. PubMed ID: 8644496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases.
    Katz U; Shoenfeld Y; Zandman-Goddard G
    Curr Pharm Des; 2011; 17(29):3166-75. PubMed ID: 21864262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.
    Mobini N; Sarela A; Ahmed AR
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):119-28; quiz 128-33. PubMed ID: 7697470
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.
    Späth PJ; Schneider C; von Gunten S
    Arch Immunol Ther Exp (Warsz); 2017 Jun; 65(3):215-231. PubMed ID: 27638480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin for autoimmune thrombocytopenic purpura.
    Bierling P; Godeau B
    Hum Immunol; 2005 Apr; 66(4):387-94. PubMed ID: 15866702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous immunoglobulın therapy in dermatology: an update.
    Çakmak SK; Çakmak Al; Gönül M; K l ç A; Gül Ü
    Inflamm Allergy Drug Targets; 2013 Apr; 12(2):132-46. PubMed ID: 23360252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous Immunoglobulin in Infantile Chronic Inflammatory Demyelinating Polyneuropathy: A Case Report.
    Cianci P; Salvatore S; Moretti A; Berardinelli A; Salvatoni A; Marinoni M; Agosti M
    J Pediatr Neurosci; 2019; 14(1):38-41. PubMed ID: 31316642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulation by hyperimmunoglobulins after solid organ transplantation: Beyond prevention of viral infection.
    van Gent R; Metselaar HJ; Kwekkeboom J
    Transplant Rev (Orlando); 2017 Apr; 31(2):78-86. PubMed ID: 28131494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous immunoglobulin in the treatment of neurologic disorders.
    Živković S
    Acta Neurol Scand; 2016 Feb; 133(2):84-96. PubMed ID: 25997034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin.
    Kondo N; Ozawa T; Mushiake K; Motoyoshi F; Kameyama T; Kasahara K; Kaneko H; Yamashina M; Kato Y; Orii T
    J Clin Immunol; 1991 May; 11(3):152-8. PubMed ID: 1890165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic administration of immunoglobulins].
    Witte T
    Z Rheumatol; 2016 Dec; 75(10):956-963. PubMed ID: 27796482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Application of intravenous immunoglobulin preparations (IVIGs) in organ transplantation].
    Senatorski G; Hryniewiecka E
    Pol Merkur Lekarski; 2011 Jun; 30(180):417-22. PubMed ID: 21751551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of action and historical facts on the use of intravenous immunoglobulins in systemic lupus erythematosus.
    Martínez T; Garcia-Robledo JE; Plata I; Urbano MA; Posso-Osorio I; Rios-Serna LJ; Barrera MC; Tobón GJ
    Autoimmun Rev; 2019 Mar; 18(3):279-286. PubMed ID: 30639648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [High dose intravenous immunoglobulins in therapeutic arsenal in autoimmune and systemic diseases].
    Klein M; Kaminsky P; Duc M
    Therapie; 1993; 48(2):97-103. PubMed ID: 8351694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases.
    Ballow M
    J Allergy Clin Immunol; 1997 Aug; 100(2):151-7. PubMed ID: 9275133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.